HIVE Stock Analysis & IQ Rating | HIVE

What is HIVE current stock price?

As of the latest update, HIVE is trading at $4.10 with a daily change of +0.74%. The 52-week range runs from $1.6 to $7.84. StocksRunner refreshes this data every 15 minutes during market hours.

What is HIVE current Stock IQ?

HIVE current StocksRunner IQ Signal is Strong Bullish. This reflects mixed or inconclusive signals across the momentum, activity, analyst rating, and growth pillars tracked by StocksRunner. The score is updated every 15 minutes during market hours.

What is HIVE RSI signal right now?

HIVE RSI is currently at 73.69. A reading above 70 is generally considered overbought territory, meaning the stock has moved significantly higher in a short period and may face near-term resistance or consolidation. The current trend classification for HIVE is Uptrend.

What is HIVE analyst price target and upside potential?

The current analyst consensus price target for HIVE is $4.60. Based on the current trading price of $4.10, this implies a potential move of +12.20%. Price targets are set by Wall Street analysts based on their fundamental models and are updated as new earnings data, guidance, or market conditions emerge. StocksRunner tracks target price changes in real time.

What do analysts say about HIVE stock?

Analyst consensus data for HIVE is monitored and updated on StocksRunner as new ratings and price target changes are published by Wall Street firms.

What is HIVE momentum trend right now?

HIVE current trend is classified as Uptrend based on price and volume pattern analysis. RSI is at 73.69, supporting this trend read. Current market positioning shows 56% bullish signals versus 22% bearish signals across the monitored data set. StocksRunner updates momentum signals every 15 minutes, giving active traders a near-real-time read on directional pressure before it is fully reflected in price.

What are HIVE stock strengths?

HIVE current signal strengths include Earnings are forecast to grow. These are identified and updated in real time by the StocksRunner IQ algorithm based on earnings data, analyst activity, and market behavior.

What is HIVE Risk Level?

HIVE carries a High risk profile based on StocksRunner assessment of volatility, sector strength, trading volume, investor confidence, and overall market outlook. Risk levels are reassessed continuously as new data becomes available.

Should I buy HIVE stock right now?

StocksRunner does not provide personalized investment advice. The current IQ Signal for HIVE is Strong Bullish. Analyst consensus stands at with a rating from 0 buy, 0 hold, and 0 sell ratings on record. Always consider your own risk tolerance and consult a financial advisor before making any investment decision.

Is HIVE a Strong Buy right now?

HIVE current Stock IQ is Strong Bullish. The analyst consensus breakdown is 0 buy, 0 hold, and 0 sell ratings, with an overall consensus of . StocksRunner updates this signal every 15 minutes.

What is HIVE market cap and volume?

HIVE market cap is 1.50B. Current daily trading volume is 34.07M versus an average daily volume of 26.30M. Volume relative to average is a key input in the StocksRunner momentum signal. Significant above-average volume often precedes or confirms meaningful price moves.

What factors influence HIVE's Stock IQ?

HIVE Stock IQ Score weighs four core pillars: Momentum (price and volume patterns, trend direction, RSI), Activity (institutional flow, insider behavior, unusual options activity), Expert Ratings (analyst consensus weighted by historical accuracy, upgrade and downgrade frequency), and Growth (earnings trajectory, forward guidance, sector competitive positioning). All four pillars are aggregated and updated every 15 minutes during market hours to produce the current IQ Signal of Strong Bullish.